Illegal Additives Testing in Health Foods: Detection of Undeclared Pharmaceutical Substances

Illegal additives testing in health foods is a critical safety control that screens dietary supplements for undeclared pharmaceutical substances such as sibutramine, sildenafil, corticosteroids, and sedatives. Accredited third-party laboratories use validated LC-MS/MS and high-resolution mass spectrometry methods, aligned with GB national standards and ISO/IEC 17025 requirements, to detect, confirm, and quantify adulterants at trace levels. This article explains the sample types, testing panels, analytical techniques, quality standards, and practical applications of illegal adulterant detection in health food products.

Health foods and dietary supplements are permitted to contain vitamins, minerals, botanical extracts, and other functional ingredients, but they must never include undeclared pharmaceutical active substances. Illegal additive testing protects consumers, brands, and regulators by verifying that finished products are free of covertly added drug ingredients.

Technical Overview

Illegal adulteration occurs when manufacturers deliberately add prescription or over-the-counter drug substances to health foods in order to deliver rapid, noticeable effects that the legitimate formulation cannot achieve. Because these substances are absent from the label, consumers cannot anticipate dose-related risks, contraindications, or drug–drug interactions. Documented consequences of adulterated supplements include severe hypoglycemia, cardiovascular events, hepatotoxicity, psychiatric disturbances, and hormonal imbalance.

Illegal additive testing is a specialized analytical discipline built on two complementary strategies. Targeted multi-residue screening uses liquid chromatography coupled to triple quadrupole mass spectrometry (LC-MS/MS) to search for known adulterant lists covering dozens to more than one hundred compounds in a single injection. Untargeted screening with high-resolution mass spectrometry (HRMS) then extends the search to unknown compounds and structural analogues designed to evade standard methods. Both approaches are supported by rigorous confirmation criteria and quantitative calibration.

Accredited third-party laboratories operating under ISO/IEC 17025 quality management systems perform this testing in accordance with GB national food safety standards, national supplementary testing methods issued by regulatory authorities, and internationally recognized method validation principles. Typical detection capability reaches the microgram-per-kilogram (parts-per-billion) range, and results are compiled into legally defensible test reports suitable for regulatory submission, product release, and supply chain verification.

Testing Samples

Testing can be performed on virtually every health food dosage form, including hard and soft capsules, tablets, coated pills, granules, powders, oral liquids, tinctures, teas, coffees, honeys, jellies, wines, and pressed candy-style supplements. Samples are handled under documented chain-of-custody procedures, homogenized, and extracted prior to instrumental analysis.

Weight-Management and Slimming Products

Slimming capsules, meal-replacement powders, herbal teas, and functional coffees are among the most frequently adulterated product categories. Common illegal additions include the withdrawn appetite suppressant sibutramine, the banned laxative phenolphthalein, antidepressants such as fluoxetine, serotonergic anorectics such as lorcaserin, and undeclared diuretics or stimulants.

Sexual Enhancement Products

Products marketed for male performance are routinely adulterated with phosphodiesterase-5 (PDE5) inhibitors such as sildenafil, tadalafil, and vardenafil, along with designer analogues including homosildenafil, hydroxyhomosildenafil, and aminotadalafil. Analogues are particularly hazardous because their toxicity has never been clinically evaluated.

Blood Glucose and Lipid Regulation Products

Supplements claiming to lower blood sugar or blood lipids may contain oral hypoglycemic agents such as glibenclamide, glipizide, metformin, or phenformin, as well as statin drugs such as lovastatin and simvastatin. Hidden antihypertensive agents including amlodipine, nifedipine, losartan, and hydrochlorothiazide are also encountered.

Anti-Inflammatory and Pain-Relief Products

Joint health, rheumatism, and topical pain-relief formulations may be adulterated with corticosteroids such as dexamethasone and prednisone, or with non-steroidal anti-inflammatory drugs including indomethacin, diclofenac, piroxicam, and paracetamol.

Sleep, Mood, and Calming Products

Products promoting sleep, relaxation, or mood improvement can contain undeclared benzodiazepines such as diazepam, estazolam, and alprazolam, the hypnotic zolpidem, or other psychotropic substances with dependence potential.

Sports Nutrition and Body-Building Products

Muscle-building and performance supplements may contain anabolic-androgenic steroids, clenbuterol and other beta-agonists, undeclared stimulants, or selective androgen receptor modulators (SARMs), all of which carry serious endocrine and cardiac risks.

Testing Items

Testing programs are organized into compound-class panels that reflect regulatory concern lists and historical adulteration patterns, and can be combined or customized to match the product and its intended claims.

• PDE5 inhibitors and their structural analogues for sexual enhancement products
• Anorectic, laxative, and diuretic agents for weight-management products
• Oral hypoglycemic drugs and statins for glucose and lipid regulation products
• Antihypertensive agents for blood pressure products
• Corticosteroids for anti-inflammatory, skin, and joint health products
• Non-steroidal anti-inflammatory drugs and analgesics for pain-relief products
• Sedative-hypnotics and psychotropic substances for sleep and mood products
• Sex hormones, anabolic steroids, and SARMs for sports nutrition products
• Beta-agonists and prohibited stimulants across all product categories
• Untargeted unknown screening for novel or designer adulterants outside established lists

Where a screening hit is obtained, the compound is confirmed by an orthogonal or high-resolution method and quantified against certified reference standards to determine the actual dosage level per serving.

Testing Methods

The analytical workflow comprises sample preparation, targeted screening, confirmation, quantification, and reporting, with each stage controlled by validated procedures and documented quality criteria.

Sample Preparation

Homing in on the dosage form, samples are homogenized and extracted with organic solvents such as methanol or acetonitrile, frequently assisted by ultrasonication or shaking. Cleanup may involve centrifugation, filtration, solid-phase extraction, or dilution to reduce matrix interference from herbal extracts, oils, proteins, and pigments. Isotope-labeled internal standards are added before extraction to correct for recovery losses and matrix effects.

LC-MS/MS Targeted Screening

Ultra-high performance liquid chromatography coupled to triple quadrupole mass spectrometry in multiple reaction monitoring (MRM) mode is the primary screening technique. It offers exceptional selectivity and sensitivity, enabling simultaneous screening of broad adulterant panels at low nanogram-per-gram levels within a single chromatographic run of ten to twenty minutes.

High-Resolution Mass Spectrometry

Quadrupole time-of-flight (Q-TOF) and Orbitrap-based LC-HRMS platforms perform untargeted screening by acquiring full-scan accurate-mass data, typically within five parts-per-million mass error, together with fragment ion spectra. Suspect and non-target workflows compare acquired data against spectral libraries and structural databases, allowing the discovery of undisclosed analogues and completely unexpected compounds that targeted MRM methods would miss.

GC-MS and HPLC Methods

Gas chromatography–mass spectrometry is applied to volatile and thermally stable adulterants, while high performance liquid chromatography with diode-array or UV detection provides cost-effective routine quantification when the target compound and reference standard are already established.

Rapid Screening Technologies

For on-site triage and high-throughput preliminary checks, near-infrared and Raman spectroscopy, thin-layer chromatography, and immunoassay test strips deliver fast indicative results. Positive rapid-screen findings must always be confirmed by laboratory chromatographic-mass spectrometric analysis before regulatory or commercial conclusions are drawn.

Method Validation and Quality Control

All methods are validated for selectivity, linearity, limits of detection and quantification, accuracy, precision, recovery, and matrix effect, in accordance with ISO/IEC 17025 laboratory competence requirements and the principles embedded in GB national standards and supplementary national testing methods. Confirmation is based on retention time agreement, ion transition ratios within defined tolerances, and mass accuracy criteria, with quantification performed using matrix-matched calibration to guarantee defensible results.

Applications

Illegal additive testing serves a wide range of compliance, safety, and commercial objectives across the health food value chain.

• Regulatory market surveillance, enforcement sampling, and case investigation by food and drug authorities
• Manufacturer quality control for incoming raw materials, contract manufacturer audits, and finished product release
• E-commerce platform and retailer supplier verification and product listing compliance
• Import and export conformity assessment and customs clearance support
• Investigation of adverse event reports and forensic support in suspected poisoning cases
• Due diligence for brand acquisitions, licensing agreements, and private-label product development
• Support for product registration, filing, and certification submissions

FAQ

What are the most frequently detected illegal additives in health foods?

Historical enforcement data show that sibutramine and phenolphthalein dominate slimming products, sildenafil and its analogues dominate sexual enhancement products, glibenclamide and phenformin appear in glucose-regulation products, dexamethasone appears in anti-inflammatory products, and benzodiazepines appear in sleep products. Combination adulteration, in which several drugs are added simultaneously, is also common and requires multi-analyte screening.

How much sample is required for testing?

A typical submission is 20 to 50 grams of product, or a minimum of ten dosage units such as capsules or tablets, to ensure the laboratory portion is representative and to reserve material for confirmatory retesting. Liquid products generally require 50 to 100 milliliters.

What sensitivity can be achieved?

Validated LC-MS/MS screening methods commonly achieve detection limits at the low microgram-per-kilogram to nanogram-per-gram range, far below pharmacologically active doses, so even minor or unevenly distributed adulteration is reliably detected.

Can unknown or designer analogues be found?

Yes. Untargeted HRMS screening with accurate mass measurement and MS/MS library searching identifies structural analogues that are not included in standard target lists, which is essential for detecting deliberately modified compounds designed to evade conventional detection.

How long does testing take?

Standard targeted panel screening is generally completed within five to ten working days after sample receipt. Untargeted investigations involving unknown identification, structural elucidation, and reference standard procurement may require additional time.

Which standards and quality frameworks apply?

Testing is performed in accredited third-party laboratories under ISO/IEC 17025 quality systems, using methods aligned with GB national food safety standards, supplementary national testing methods for illegal additives, and internationally recognized chromatographic and mass spectrometric method validation guidelines.